Johnson & Johnson
Trade Johnson & Johnson 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About JNJ
Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments.
JNJ Key Statistics
Stock Snapshot
With a market cap of 671.23B, Johnson & Johnson(JNJ) trades at $276.93. The stock has a price-to-earnings ratio of 42.86 and currently yields dividends of 1.87%.
On 2026-11-18, Johnson & Johnson(JNJ) stock traded between a low of $276.61 and a high of $281.72. Shares are currently priced at $276.93, which is +0.1% above the low and -1.7% below the high.
Johnson & Johnson(JNJ) shares are trading with a volume of 8.98M, against a daily average of 8.01M.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $290.25 and a 52-week low of $198.53.
In the last year, Johnson & Johnson(JNJ) shares hit a 52-week high of $290.25 and a 52-week low of $198.53.
JNJ News
BofA raised the firm’s price target on Johnson & Johnson to $292 from $275 and keeps a Neutral rating on the shares. The company enters its December 8th Enterp...
Healthcare investors often choose between established stability and high-growth innovation. Determining whether Johnson & Johnson (JNJ -1.36%) or Vertex Pharmac...
...
Analyst ratings
67%
of 27 ratingsMore JNJ News
Johnson & Johnson: Steady Upward Recent Revenue Growth Johnson & Johnson (JNJ -0.97%) primarily generates revenue by developing and selling pharmaceutical and m...
Johnson & Johnson (JNJ) is back in focus after reports that it is negotiating a potential Ollin Biosciences acquisition valued at up to US$3.4b, a move watched...
Johnson & Johnson (JNJ Quick QuoteJNJ - Free Report) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some...
Johnson & Johnson: A Steady Revenue Uptrend Johnson & Johnson (JNJ -1.12%) primarily generates revenue by developing and selling pharmaceutical treatments and m...
Johnson & Johnson (NYSE:JNJ) on Monday agreed to acquire Ollin Biosciences, a clinical-stage biopharmaceutical company focused on therapies for serious eye dise...
It sounds nuts, but SoFi is giving new Active Invest users up to $1,000 in stock for a limited time, and all it takes is a $50 deposit to get started. See for y...
Ollin’s main experimental drug is designed to treat eye diseases that can cause vision loss. The purchase marks an expansion into eye medicines for J&J, which a...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.